Burkitt lymphoma: a retrospective analysis of data from the Registry of the Czech Lymphoma Study Group with external validation of the Burkitt lymphoma International Prognostic Index

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F22%3A00013498" target="_blank" >RIV/00023736:_____/22:00013498 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/22:10452210 RIV/00216208:11120/22:43924481 RIV/00216208:11130/22:10452210 RIV/00216208:11150/22:10452210 and 6 more
Result on the web
<a href="https://doi.org/10.4149/neo_2022_221030N1064" target="_blank" >https://doi.org/10.4149/neo_2022_221030N1064</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.4149/neo_2022_221030N1064" target="_blank" >10.4149/neo_2022_221030N1064</a>

Result language
angličtina
Original language name
Burkitt lymphoma: a retrospective analysis of data from the Registry of the Czech Lymphoma Study Group with external validation of the Burkitt lymphoma International Prognostic Index
Original language description
Burkitt lymphoma (BL) is a rare subtype of non-Hodgkin’s lymphoma with an aggressive course. The aim of the current project was to perform an external validation of the BL-IPI in 101 patients from the Registry of Czech Lymphoma Study Group diagnosed between 1999 and 2016 (median age, 45 years).
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30205 - Hematology

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)